Skip to content

CytoSorb therapy in ECMO patients – an update

Chair: Prof. Manu Malbrain, Brussels/Belgium and Prof. Ralf Muellenbach, Kassel/Germany

  • Overwhelming inflammation in ECMO – when and how to face it?
    Prof. Leonardo Gottin, Verona/Italy
  • Early use of cytokine adsorption in severe COVID-19 pneumonia requiring VV-ECMO – first results from the CYCOV trial
    Dr. Alexander Supady, Freiburg/Germany
  • Can VV-ECMO patients with severe pneumogenic sepsis benefit from CytoSorb therapy? Results from a retrospective study
    Dr. Ali Akil, Ibbenbueren/Germany
Play Video

Share

|

CytoSorb therapy in ECMO patients – an update

Play Video

Share

|

Chair: Prof. Manu Malbrain, Brussels/Belgium and Prof. Ralf Muellenbach, Kassel/Germany

  • Overwhelming inflammation in ECMO – when and how to face it?
    Prof. Leonardo Gottin, Verona/Italy
  • Early use of cytokine adsorption in severe COVID-19 pneumonia requiring VV-ECMO – first results from the CYCOV trial
    Dr. Alexander Supady, Freiburg/Germany
  • Can VV-ECMO patients with severe pneumogenic sepsis benefit from CytoSorb therapy? Results from a retrospective study
    Dr. Ali Akil, Ibbenbueren/Germany